Presentation Controversies and Advances 2023 Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward Presenter: Michael Mack November 30, 2023
Presentation ACC 2022 5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials Presenter: Michael J. Reardon April 04, 2022
Presentation TCT Abstracts Posters 2019 Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion Presenter: Michael DiVita October 09, 2019
Presentation TVT 2017 The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs Presenter: Robert O. Bonow, Martin B. Leon, Michael J. Mack June 15, 2017
Presentation TVT 2017 A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack June 15, 2017
Presentation SWVS 2017 Heart Valve Dysfunction With ESRD: Options and Expectations Presenter: Michael J. Reardon May 06, 2017
Presentation TVT 2016 Technique and Outcomes of Surgery for Tricuspid Regurgitation Presenter: Michael A. Borger June 17, 2016
Presentation Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR Presenter: G. Michael Deeb April 06, 2016
Presentation 2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR Presenter: Michael J. Reardon July 06, 2015
Presentation Fellows 2015 Update on Mitral Valve Disease and Transcatheter Therapies Presenter: Mark Reisman, Nirat Beohar, Michael J. Rinaldi May 17, 2015
Presentation ACC 2015 Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Presenter: Michael J. Mack March 15, 2015
Presentation ACC 2015 A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes Presenter: Michael J. Reardon March 15, 2015
Presentation Predictors and Clinical Impact of Preexisting andAcquired Thrombocytopenia Following TAVR Presenter: Michael P. Flaherty October 14, 2014
Presentation TCT 2014 TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia September 16, 2014
Presentation TCT 2014 Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim September 16, 2014
Presentation TCT 2014 A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon September 16, 2014
Presentation TCT 2014 Clinical Indications for TAVR: Where are We and Where are We Going? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein September 16, 2014
Presentation TCT 2014 Con: Ignore Aortic Regurgitation at Your Own Risk! Presenter: Simon Redwood, Michael J. Mack September 15, 2014
Presentation TCT 2014 The Five Multislice CT Essentials for Optimal TAVR Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Jonathon A. Leipsic September 14, 2014
Presentation TCT 2014 The Five Echocardiographic Essentials for Optimal TAVR Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn September 14, 2014